Single-cell transcription site activation predicts chemotherapy response in human colorectal tumors

Cancer Research

Volumn 68, Issue 13, 2008, Pages 4977-4982

  Pezo, Rossanna C ^a   Gandhi, Saumil J ^a   Shirley, L Andrew ^b   Pestell, Richard G ^b   Augenlicht, Leonard H ^a   Singer, Robert H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MESSENGER RNA; ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC AGENT; BAK1 PROTEIN, HUMAN; CATION TRANSPORT PROTEIN; MORF4L2 PROTEIN, HUMAN; PHARMACOLOGICAL BIOMARKER; PROTEIN BAK; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR; WILSON DISEASE PROTEIN;

ARTICLE; ATPASE COPPER TRANSPORTING BETA POLYPEPTIDE GENE; BCL2 ANTAGONIST KILLER GENE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL COUNT; COLORECTAL CANCER; COLORECTAL TUMOR; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MORF RELATED GENE X; PRIORITY JOURNAL; THYMIDYLATE SYNTHASE GENE; TRANSCRIPTION INITIATION; ALGORITHM; CARCINOMA; CELL STRAIN HCT116; DRUG RESISTANCE; EVALUATION; GENETICS; PHYSIOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; TRANSCRIPTION INITIATION SITE; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATASES; ALGORITHMS; ANTINEOPLASTIC AGENTS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BIOMARKERS, PHARMACOLOGICAL; CARCINOMA; CATION TRANSPORT PROTEINS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; HCT116 CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE;

EID: 48549105218     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-6770     Document Type: Article

References (17)

1. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003;3:330-8.
2. Leichman CG, Lenz HJ, Leichman L, et al. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 1997;15:3223-9.
3. Salonga D, Danenberg KD, Johnson M, et al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 2000;6:1322-7.
4. Metzger R, Danenberg K, Leichman CG, et al. High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. Clin Cancer Res 1998;4:2371-6.
5. Elsaleh H, Iacopetta B. Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma. Clin Colorectal Cancer 2001;1:104-9.
6. Elsaleh H, Powell B, McCaul K, et al. P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res 2001;7:1343-9.
7. Goh HS, Yao J, Smith DR. p53 point mutation and survival in colorectal cancer patients. Cancer Res 1995;55:5217-21.
8. Benhattar J, Cerottini JP, Saraga E, Metthez G, Givel JC. p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas. Int J Cancer 1996;69:190-2.
9. Ahnen DJ, Feigl P, Quan G, et al. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res 1998;58:1149-58.
10. Arango D, Corner GA, Wadler S, Catalano PJ, Augenlicht LH. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo. Cancer Res 2001;61:4910-5.
11. Augenlicht LH, Wadler S, Corner G, et al. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial. Cancer Res 1997;57:1769-75.
12. Mariadason JM, Arango D, Shi Q, et al. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res 2003;63:8791-812.
13. Arango D, Wilson AJ, Shi Q, et al. Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. Br J Cancer 2004;91:1931-46.
14. Levsky JM, Singer RH. Gene expression and the myth of the average cell. Trends Cell Biol 2003;13:4-6.
15. Femino AM, Fay FS, Fogarty K, Singer RH. Visualization of single RNA transcripts in situ. Science 1998;280:585-90.
16. Levsky JM, Shenoy SM, Pezo RC, Singer RH. Singlecell gene expression profiling. Science 2002;297:836-40.
17. Capodieci P, Donovan M, Buchinsky H, et al. Gene expression profiling in single cells within tissue. Nat Methods 2005;2:663-5.